MX2009008495A - Novedosos analogos de nucleosidos para el tratamiento de infecciones virales. - Google Patents

Novedosos analogos de nucleosidos para el tratamiento de infecciones virales.

Info

Publication number
MX2009008495A
MX2009008495A MX2009008495A MX2009008495A MX2009008495A MX 2009008495 A MX2009008495 A MX 2009008495A MX 2009008495 A MX2009008495 A MX 2009008495A MX 2009008495 A MX2009008495 A MX 2009008495A MX 2009008495 A MX2009008495 A MX 2009008495A
Authority
MX
Mexico
Prior art keywords
treatment
viral infections
nucleoside analogs
novel nucleoside
novel
Prior art date
Application number
MX2009008495A
Other languages
English (en)
Spanish (es)
Inventor
Jeyaraj Duraiswamy
Zheng Yin
Yen Liang Chen
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39462074&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2009008495(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2009008495A publication Critical patent/MX2009008495A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MX2009008495A 2007-02-09 2008-02-07 Novedosos analogos de nucleosidos para el tratamiento de infecciones virales. MX2009008495A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07102027 2007-02-09
EP08150003 2008-01-02
PCT/EP2008/051527 WO2008095993A1 (en) 2007-02-09 2008-02-07 Novel nucleoside analogs for treatment of viral infections

Publications (1)

Publication Number Publication Date
MX2009008495A true MX2009008495A (es) 2009-08-20

Family

ID=39462074

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009008495A MX2009008495A (es) 2007-02-09 2008-02-07 Novedosos analogos de nucleosidos para el tratamiento de infecciones virales.

Country Status (18)

Country Link
US (1) US8278282B2 (https=)
EP (1) EP2132216B1 (https=)
JP (1) JP2010518047A (https=)
KR (1) KR20090109102A (https=)
CN (1) CN101600726B (https=)
AR (1) AR065249A1 (https=)
AT (1) ATE533774T1 (https=)
AU (1) AU2008212752A1 (https=)
BR (1) BRPI0807222A2 (https=)
CA (1) CA2675462A1 (https=)
CL (1) CL2008000409A1 (https=)
EA (1) EA200901080A1 (https=)
ES (1) ES2381093T3 (https=)
MX (1) MX2009008495A (https=)
PE (1) PE20090070A1 (https=)
PT (1) PT2132216E (https=)
TW (1) TW200838550A (https=)
WO (1) WO2008095993A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010015643A1 (en) * 2008-08-06 2010-02-11 Novartis Ag New antiviral modified nucleosides
CN102526087B (zh) * 2010-12-30 2014-09-03 南开大学 核苷类化合物在制备治疗肠病毒71(ev71)感染疾病药物的应用
CN105669783B (zh) * 2014-12-03 2019-11-12 广东东阳光药业有限公司 一种制备呋喃糖的方法
EA201890454A1 (ru) 2015-08-06 2018-07-31 Чимерикс, Инк. Пирролопиримидиновые нуклеозиды и их аналоги, которые можно использовать в качестве противовирусных средств
CN108289931B (zh) 2015-09-23 2022-10-11 默沙东公司 4’-取代的核苷逆转录酶抑制剂及其制备
EA201892448A1 (ru) * 2016-04-28 2019-06-28 Эмори Юниверсити Алкинсодержащие нуклеотидные и нуклеозидные терапевтические композиции и связанные с ними способы применения
TW201815821A (zh) * 2016-07-18 2018-05-01 美商再生元醫藥公司 抗茲卡病毒抗體及使用方法
AU2017311566A1 (en) * 2016-08-12 2019-02-21 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
WO2019060692A1 (en) 2017-09-21 2019-03-28 Chimerix, Inc. MORPHIC FORMS OF 4-AMINO-7- (3,4-DIHYDROXY-5- (HYDROXYMETHYL) -ETRAHYDROFURAN-2-YL) -2-METHYL-7H-PYRROLO [2,3-D] PYRIMIDINE-5-CARBOXAMIDE AND THEIR USES
US11718534B2 (en) 2019-04-23 2023-08-08 Elementis Specialties, Inc. Slurry compositions containing mixed branched alkyl organoclay compositions
MX2024007822A (es) * 2021-12-22 2024-07-04 Cj Cheiljedang Corp Composicion antiviral que comprende analogos nucleosidicos derivados de acido nucleico y sal farmaceuticamente aceptable de los mismos.
WO2024012568A1 (en) * 2022-07-15 2024-01-18 Sunshine Lake Pharma Co., Ltd. A key intermediate for preparing glucopyranosyl derivatives and preparation method thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002057425A2 (en) * 2001-01-22 2002-07-25 Merck & Co., Inc. Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
WO2003051352A1 (en) * 2001-12-14 2003-06-26 Alcon, Inc. Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma
JP2005527499A (ja) * 2002-02-13 2005-09-15 メルク　エンド　カムパニー　インコーポレーテッド ヌクレオシド化合物を用いてオルトポックスウイルスの複製を阻害する方法
AU2003232071A1 (en) * 2002-05-06 2003-11-17 Genelabs Technologies, Inc. Nucleoside derivatives for treating hepatitis c virus infection
AU2003279797B2 (en) * 2002-09-30 2009-10-22 Genelabs Technologies, Inc. Nucleoside derivatives for treating hepatitis C virus infection
US20040259934A1 (en) * 2003-05-01 2004-12-23 Olsen David B. Inhibiting Coronaviridae viral replication and treating Coronaviridae viral infection with nucleoside compounds
JP2007509939A (ja) * 2003-10-27 2007-04-19 ジェネラブズ テクノロジーズ インコーポレーティッド ウイルス感染を治療するためのヌクレオシド化合物

Also Published As

Publication number Publication date
CN101600726B (zh) 2013-03-27
PT2132216E (pt) 2012-02-20
US8278282B2 (en) 2012-10-02
ATE533774T1 (de) 2011-12-15
AR065249A1 (es) 2009-05-27
CA2675462A1 (en) 2008-08-14
US20100227833A1 (en) 2010-09-09
WO2008095993A1 (en) 2008-08-14
AU2008212752A1 (en) 2008-08-14
JP2010518047A (ja) 2010-05-27
CL2008000409A1 (es) 2008-08-29
ES2381093T3 (es) 2012-05-23
KR20090109102A (ko) 2009-10-19
BRPI0807222A2 (pt) 2014-04-29
EA200901080A1 (ru) 2010-02-26
EP2132216B1 (en) 2011-11-16
TW200838550A (en) 2008-10-01
PE20090070A1 (es) 2009-03-19
EP2132216A1 (en) 2009-12-16
CN101600726A (zh) 2009-12-09

Similar Documents

Publication Publication Date Title
MX2009008495A (es) Novedosos analogos de nucleosidos para el tratamiento de infecciones virales.
GEP201706793B (en) Substituted nucleosides, nucleotides and analogs thereof
PH12012502284A1 (en) Antiviral nucleoside analogs
MX2009013830A (es) Compuestos antivirales.
MX2009013827A (es) Compuestos antivirales.
MX2009011533A (es) Productos quimicos, composiciones y metodos para tratamiento y prevencion de infecciones de virus orthopox y enfermedades asociadas.
GEP20135964B (en) Inhibitors of beta-secretase
WO2009026179A3 (en) Antiinfective proanthocyanidin compounds and methods of use thereof
WO2008127364A3 (en) Antiviral compounds and use thereof
MX2010005136A (es) Prevencion y tratamiento de infecciones secundarias tras una infeccion viral.
IN2012DN00869A (https=)
GEP20156313B (en) Substituted nucleotide analogs
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
TW200738741A (en) Antiviral compounds
TW200738742A (en) Antiviral compounds
MX2012002031A (es) Moleculas pequeñas que contienen boro como agentes antiprotozoarios.
EA200970916A1 (ru) Соединения 5,6-дигидро-1н-пиридин-2-она
UA94749C2 (en) Benzimidazole modulators of vr1
WO2010029302A3 (en) Compounds for treating viral infections
PH12015502588B1 (en) 4`-fluoro-2`-methyl substituted nucleoside derivatives
MX2015011193A (es) Compuestos antivirales.
ZA202001780B (en) Bezimidazole derivatives as adenosine receptor antagonists
CA3010327A1 (en) Aryl substituted pyrimidines for use in influenza virus infection
WO2007120374A3 (en) Anti-arenaviral compounds
IN2014CN00572A (https=)

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration